Novel blood test detects lung cancer traces long before scans
Despite advances in early-stage lung cancer treatment, a significant number of patients experience disease recurrence after surgery or initial therapy. A study has now demonstrated that a blood test (liquid biopsy) can reliably detect lingering lung cancer traces even in the earliest clinical stages, long before a tumor is large enough to show up on a scan. This real-time genetic monitoring…
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
